The study, published in JAMA Neurology, was conducted at two hospitals in New York City. It included 1,916 adult patients with COVID-19 who visited the emergency department or were hospitalized between March 4 and May 2. Researchers compared the COVID-19 patients with 1,486 adults with the flu who visited the emergency department or were hospitalized between Jan. 1, 2016 and May 31, 2018.
Researchers found that 31 (1.6 percent) of the 1,916 COVID-19 patients had an acute ischemic stroke, compared to three (0.2 percent) of the 1,486 flu patients.
After adjusting for age, sex and race, the likelihood of stroke was about seven times higher among the COVID-19 patients than with the flu patients.
More articles on patient safety & outcomes:
10% drop in ER volume significantly cuts patient death rates, study finds
Obesity common among kids hospitalized with COVID-19, study finds
76% of COVID-19 patients treated with convalescent plasma improve, small study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
